DLA Piper advises Graham Partners on New Pharma Services Platform Quantive Intelligence

DLA Piper advised private investment firm Graham Partners on the formation of Quantive Intelligence (QI), a decision sciences platform created through the acquisitions of TechData Service Company, LLC, LLX Solutions, LLC, and R Square Technology, Inc.

QI was formed to serve as a platform that transforms complex clinical data into clear, actionable insights that support regulatory approvals. The combined organization brings specialized capabilities in biostatistics, statistical programming, and data management, helping pharmaceutical and biotechnology companies navigate increasingly complex clinical development and regulatory requirements.

The DLA Piper deal team included Partners Andrew Gilbert, Scott Cowan, and Dylan Caplan.

With more than 1,000 corporate lawyers globally, DLA Piper helps clients execute complex transactions seamlessly while supporting clients across all stages of development. The firm has been rated number one in global M&A volume for 16 consecutive years by Mergermarket.

With more than 400 life sciences professionals worldwide, DLA Piper delivers seamless, tailored solutions across every stage of the business lifecycle. Our team includes medical doctors, PhDs, and industry veterans who bring extensive scientific and legal knowledge and experience to every challenge. We combine modern insights with an expansive geographic footprint to help clients anticipate risk, maximize opportunity, and stay ahead in a rapidly evolving landscape. Whether navigating complex regulations or defending innovation, we work as one—offering bold, agile strategies and value-added counsel that keep science on your side.